Filing Details
- Accession Number:
- 0001447362-25-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-08 18:19:37
- Reporting Period:
- 2025-01-06
- Accepted Time:
- 2025-01-08 18:19:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447362 | Castle Biosciences Inc | CSTL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236397 | Daniel Bradbury | C/O Castle Biosciences, Inc. 505 S. Friendswood Drive, Suite 401 Friendswood TX 77546 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-06 | 1,530 | $28.39 | 8,504 | No | 4 | S | Indirect | By LLC |
| Common Stock | Disposition | 2025-01-06 | 434 | $28.39 | 2,416 | No | 4 | S | Indirect | By Daniel Bradbury Irrevocable Descendant's Trust |
| Common Stock | Disposition | 2025-01-06 | 434 | $28.39 | 2,416 | No | 4 | S | Indirect | By Annette Bradbury Irrevocable Descendant's Trust |
| Common Stock | Disposition | 2025-01-06 | 3,015 | $29.41 | 5,489 | No | 4 | S | Indirect | By LLC |
| Common Stock | Disposition | 2025-01-06 | 857 | $29.41 | 1,559 | No | 4 | S | Indirect | By Daniel Bradbury Irrevocable Descendant's Trust |
| Common Stock | Disposition | 2025-01-06 | 857 | $29.41 | 1,559 | No | 4 | S | Indirect | By Annette Bradbury Irrevocable Descendant's Trust |
| Common Stock | Disposition | 2025-01-06 | 472 | $29.82 | 5,017 | No | 4 | S | Indirect | By LLC |
| Common Stock | Disposition | 2025-01-06 | 134 | $29.82 | 1,425 | No | 4 | S | Indirect | By Daniel Bradbury Irrevocable Descendant's Trust |
| Common Stock | Disposition | 2025-01-06 | 134 | $29.82 | 1,425 | No | 4 | S | Indirect | By Annette Bradbury Irrevocable Descendant's Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By LLC |
| No | 4 | S | Indirect | By Daniel Bradbury Irrevocable Descendant's Trust |
| No | 4 | S | Indirect | By Annette Bradbury Irrevocable Descendant's Trust |
| No | 4 | S | Indirect | By LLC |
| No | 4 | S | Indirect | By Daniel Bradbury Irrevocable Descendant's Trust |
| No | 4 | S | Indirect | By Annette Bradbury Irrevocable Descendant's Trust |
| No | 4 | S | Indirect | By LLC |
| No | 4 | S | Indirect | By Daniel Bradbury Irrevocable Descendant's Trust |
| No | 4 | S | Indirect | By Annette Bradbury Irrevocable Descendant's Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,291 | Direct |
Footnotes
- These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, Daniel Bradbury Irrevocable Descendant's Trust, and Annette Bradbury Irrevocable Descendant's Trust on May 10, 2024.
- This transaction was executed in multiple trades at prices ranging from $27.78 to $28.73, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
- Held by Daniel Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries.
- Held by Annette Bradbury Irrevocable Descendant's Trust of which the Reporting Person and his spouse are trustees and their children are beneficiaries.
- This transaction was executed in multiple trades at prices ranging from $28.84 to $29.77, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $29.78 to $29.87, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
